DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Camlin Fine Sciences Limited (CAMLINFINE) share price today?

Camlin Fine Sciences Limited (CAMLINFINE) is trading at ₹93.27 on the NSE, up 4.22% on the day. Source: DocStoX.

What is the PE ratio of Camlin Fine Sciences Limited?

Camlin Fine Sciences Limited has a price-to-earnings (PE) ratio of 63.9 in the Chemicals sector.

What is the market capitalisation of Camlin Fine Sciences Limited?

Camlin Fine Sciences Limited has a market capitalisation of approximately ₹1,828 crore.

Is Camlin Fine Sciences Limited a profitable company?

Camlin Fine Sciences Limited generates a return on equity of 2.7% with a net profit margin of 1.4%. That is a modest return on shareholder capital.

What is the 52-week high and low of CAMLINFINE?

Camlin Fine Sciences Limited (CAMLINFINE) has traded between ₹88.16 and ₹204.57 over the past 52 weeks, against a current price of ₹93.27.

Camlin Fine Sciences Limited

₹93.27▲ +3.78 (+4.22%)

CAMLINFINE·NSE·Chemicals

Market Cap

1827.99 Cr

PE Ratio

63.88

Volume

3,10,016

Day High - Low

93.30 - 89.25

52W High-Low

204.57 - 88.16

₹93.27▲ +3.78 (+4.22%)

Market Cap1827.99 Cr

PE Ratio63.88

Volume3,10,016

Day High - Low93.30 - 89.25

52W High-Low204.57 - 88.16

Camlin Fine Sciences Limited (CAMLINFINE): company summary

The company's annual revenue rose 5.8% to ₹1,723 crore, but net profit swung from a loss of ₹158 crore to a profit of ₹24 crore.

Camlin Fine Sciences Limited (CAMLINFINE) is a micro-cap Chemicals company valued at ₹1,828 crore operating in Specialty Chemicals on the NSE and BSE.

Recent price move: Camlin Fine Sciences Limited last traded at ₹93.27, up 4.22% on the day.
Recent developments: On 2026-06-30, the company reported a net loss of ₹34 crore for the latest quarter, compared to a loss of ₹11 crore in the same quarter a year earlier. Domestic institutional holding fell by 2.28 percentage points to 5.42% as of 2026-06-30.
Financial performance: The company's annual revenue rose 5.8% to ₹1,723 crore, but net profit swung from a loss of ₹158 crore to a profit of ₹24 crore. The latest quarter saw revenue rise 27.4% year-on-year to ₹520 crore, but the net profit turned into a loss of ₹34 crore, widening from a loss of ₹11 crore a year earlier.
Valuation multiples: The stock trades at 63.9 times earnings, 1.92 times book value.
Things to watch: The latest quarter net profit widened to a loss of ₹34 crore, reversing the annual profit of ₹24 crore. Promoter shares pledged account for 16.21% of promoter holding, and the stock is 57.1% below its 52-week high.
Where it stands: The company ended the latest quarter with a net loss of ₹34 crore, despite a 27.4% rise in revenue. The stock is 57.1% below its 52-week high, and promoter shares pledged make up 16.21% of promoter holding. The latest quarter net loss is the key figure showing the company's current position.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score

0.6/10

Poor

Fair Value

ROE

2.65%

Weak

P/E

63.88x

Expensive

Debt / Equity

0.69

Moderate

Industry

Chemicals

Specialty Chemicals

Overall View

Poor

Price performance

Day₹89.25

₹93.30

52W₹88.16

₹204.57

DocStoX take

Held back by momentum (0.0).

DocStoX score

Low confidence

0.6

/10

Poor

Quality

Weak

ROE 2.7%

Valuation

Expensive

P/E 63.9×

Growth

Flat

Revenue +7.7% 5Y CAGR

Risk

Elevated

D/E 0.69

Momentum

Weak

4% of 52-week range

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹93

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹1,828 Cr

52W High / Low

₹205 / ₹88

Dividend Yield

0.00%

Promoter Holding

48.03%

EPS (TTM)

₹1.46

Book Value

₹54.19

Key highlights

Profit shrinking 18% a year
16% of promoter holding is pledged

0 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Chemicals stocks · Specialty Chemicals

Explore Camlin Fine Sciences Limited’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Camlin Fine Sciences Limited peers in Chemicals

Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.

Related tools & concepts

Value Camlin Fine Sciences Limited with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

CAMLINFINE newsLatest coverage & filings Open screenerFilter the whole market